These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11497487)

  • 1. Conversion from troglitazone to rosiglitazone.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2001; 7(4):326. PubMed ID: 11497487
    [No Abstract]   [Full Text] [Related]  

  • 2. [New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000].
    Stiefelhagen P
    Internist (Berl); 2000 Sep; 41(9):930-2. PubMed ID: 11041699
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
    King AB
    Diabetes Care; 2000 Apr; 23(4):557. PubMed ID: 10857952
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic injury due to troglitazone.
    Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
    Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary edema associated with troglitazone therapy.
    Hirsch IB; Kelly J; Cooper S
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA reviews troglitazone.
    Donnelly R
    Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
    [No Abstract]   [Full Text] [Related]  

  • 9. How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy SS
    Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
    [No Abstract]   [Full Text] [Related]  

  • 10. The rise and fall of troglitazone.
    Bailey CJ
    Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
    [No Abstract]   [Full Text] [Related]  

  • 11. Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect.
    Sakurai A; Hashizume K
    Arch Intern Med; 2000 Jan; 160(1):118-9. PubMed ID: 10632316
    [No Abstract]   [Full Text] [Related]  

  • 12. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
    Parker JC
    Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 14. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute rhabdomyolysis associated with troglitazone.
    Yokoyama M; Izumiya Y; Yoshizawa M; Usuda R
    Diabetes Care; 2000 Mar; 23(3):421-2. PubMed ID: 10868879
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice.
    Gegick CG; Altheimer MD
    Endocr Pract; 2001; 7(3):162-9. PubMed ID: 11421562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleuropulmonary disease in a man with diabetes who was treated with troglitazone.
    Koshida H; Shibata K; Kametani T
    N Engl J Med; 1998 Nov; 339(19):1400-1. PubMed ID: 9841315
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
    Blonde L; Sandberg MI; Guthrie RD
    Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262
    [No Abstract]   [Full Text] [Related]  

  • 19. A drug interaction between troglitazone and simvastatin.
    Lin JC; Ito MK
    Diabetes Care; 1999 Dec; 22(12):2104-6. PubMed ID: 10587866
    [No Abstract]   [Full Text] [Related]  

  • 20. Does pioglitazone, like troglitazone, increase serum levels of lipoprotein(a) in diabetic patients?
    Nagai Y; Abe T; Nomura G
    Diabetes Care; 2001 Feb; 24(2):408-9. PubMed ID: 11213903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.